Implant Sciences’ Discusses Boston Marathon Bombing
WILMINGTON, Mass., April 9, 2015 /PRNewswire/ — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that Former Assistant Secretary for the Department of Homeland Security and Implant Sciences Corporation Executive Vice President, Robert Liscouski, was interviewed on Bloomberg TV about the Boston Marathon Bombing verdict. Mr. Liscouski discussed the vulnerabilities and potential for similar attacks in the future.
“The US is the leader in the development of technologies, including Explosives Trace Detection. While it isn’t realistic to think we can stop every terrorist incident, we can use these technologies like ETD to detect and prevent incidents and lessen the severity of them,” stated Mr. Liscouski.